Rachel Rosenthal

Title: Rachel Rosenthal: Innovator in Cancer Research

Introduction

Rachel Rosenthal is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly in the area of immune checkpoint interventions and HLA allele analysis in tumors. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.

Latest Patents

Rachel's latest patents include "Analysis of HLA alleles in tumours and the uses thereof." This invention relates to a method for determining whether an HLA allele is lost in a tumor in a subject. The method involves determining the specific copy number of the HLA allele in the tumor. Additionally, it encompasses a method for treating cancer by targeting a neoantigen presented by an HLA molecule that has not been lost in the tumor. Another notable patent is "Immune checkpoint intervention in cancer," which focuses on identifying subjects with cancer suitable for immune checkpoint treatment and predicting their prognosis.

Career Highlights

Throughout her career, Rachel has worked with esteemed organizations such as Cancer Research Technology Limited and The Francis Crick Institute Limited. Her innovative approaches and research have garnered attention in the scientific community, contributing to the understanding and treatment of cancer.

Collaborations

Rachel has collaborated with notable colleagues, including Nicholas McGranahan and Charles Swanton. These partnerships have further enhanced her research and the impact of her inventions in the field of oncology.

Conclusion

In summary, Rachel Rosenthal is a trailblazer in cancer research, with her patents and collaborations significantly advancing the understanding and treatment of cancer. Her work continues to inspire future innovations in the medical field.